Dear Dr Dibyendu,
Greetings from Applied Bioscience and congratulations for conducting this CME!
Thank you for touching upon the most important subject about “alternative to conventional platelet function study”.
I am enclosing herewith three articles – emphasizing the need to obtain pharmacogenetic Dx test report for CYP2C19 mutation status within 24-48 hours, and consequences of delay in receiving the report, or worst.. not doing this test at-all. This is current situation in India.
.
Western world has began adopting this technology : http://www.spartanbio.com/rx
I am eager to know, when will Indian centres begin to offer this service to patients? Hope your CME covers this subject during the session. Congratulations once again Dr.De, because possibly this is first time I noticed, esteemed Hematologists and Intervention Cardiologists are addressing the Coagulation Disorder topic together as a team.
Best wishes for your tomorrow’s event!
.
We would be glad to receive Slide Deck presented there, post CME.
Best regards,
Thanking you and assuring you of best of our attention and service always,
Yours sincerely,
for Applied Bioscience Consultants & Distributors
Tushar Barad, Director,
Office#4, Green Meadows 5F,
Lokhandwala Township, Kandivali(E), Mumbai-400101. India.
Tel: +91-22-2966 0575 Fax:+91-22-2966 3990
Email: tus...@appliedbioscience.com Cell : 93213 46320
--
You received this message because you are subscribed to the Google Groups "hematologyindia" group.
To unsubscribe from this group and stop receiving emails from it, send an email to hematologyind...@googlegroups.com.
To post to this group, send email to hematol...@googlegroups.com.
Visit this group at https://groups.google.com/group/hematologyindia.
To view this discussion on the web visit https://groups.google.com/d/msgid/hematologyindia/93c6405a-71c8-4560-81aa-124a5d802dda%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.